山河药辅：2025年第三季度归属于上市公司股东的净利润同比增长46.99%

Core Insights - The company reported a revenue of 225,663,160.30 yuan for the third quarter of 2025, representing a year-on-year growth of 16.06% [2] - The net profit attributable to shareholders of the listed company was 39,528,758.33 yuan, showing a significant year-on-year increase of 46.99% [2] Financial Performance - Revenue for Q3 2025: 225.66 million yuan, up 16.06% year-on-year [2] - Net profit for Q3 2025: 39.53 million yuan, up 46.99% year-on-year [2]